These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

183 related items for PubMed ID: 21194953

  • 1. Computational approach to the identification of novel Aurora-A inhibitors.
    Morshed MN, Cho YS, Seo SH, Han KC, Yang EG, Pae AN.
    Bioorg Med Chem; 2011 Jan 15; 19(2):907-16. PubMed ID: 21194953
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. A specific pharmacophore model of Aurora B kinase inhibitors and virtual screening studies based on it.
    Wang HY, Li LL, Cao ZX, Luo SD, Wei YQ, Yang SY.
    Chem Biol Drug Des; 2009 Jan 15; 73(1):115-26. PubMed ID: 19152640
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Identification of novel polo-like kinase 1 inhibitors by a hybrid virtual screening.
    Lu S, Sun SL, Liu HC, Chen YD, Yuan HL, Gao YP, Yang P, Lu T.
    Chem Biol Drug Des; 2012 Aug 15; 80(2):328-39. PubMed ID: 22583481
    [Abstract] [Full Text] [Related]

  • 6. Pharmacophore identification, virtual screening and biological evaluation of prenylated flavonoids derivatives as PKB/Akt1 inhibitors.
    Dong X, Zhou X, Jing H, Chen J, Liu T, Yang B, He Q, Hu Y.
    Eur J Med Chem; 2011 Dec 15; 46(12):5949-58. PubMed ID: 22027102
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Single step synthesis of new fused pyrimidine derivatives and their evaluation as potent Aurora-A kinase inhibitors.
    Shaaban MR, Saleh TS, Mayhoub AS, Farag AM.
    Eur J Med Chem; 2011 Sep 15; 46(9):3690-5. PubMed ID: 21664013
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Synthesis, biological evaluation, and molecular docking studies of 1,3,4-thiadiazol-2-amide derivatives as novel anticancer agents.
    Yang XH, Xiang L, Li X, Zhao TT, Zhang H, Zhou WP, Wang XM, Gong HB, Zhu HL.
    Bioorg Med Chem; 2012 May 01; 20(9):2789-95. PubMed ID: 22503364
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Discovery of a potent and selective aurora kinase inhibitor.
    Oslob JD, Romanowski MJ, Allen DA, Baskaran S, Bui M, Elling RA, Flanagan WM, Fung AD, Hanan EJ, Harris S, Heumann SA, Hoch U, Jacobs JW, Lam J, Lawrence CE, McDowell RS, Nannini MA, Shen W, Silverman JA, Sopko MM, Tangonan BT, Teague J, Yoburn JC, Yu CH, Zhong M, Zimmerman KM, O'Brien T, Lew W.
    Bioorg Med Chem Lett; 2008 Sep 01; 18(17):4880-4. PubMed ID: 18678489
    [Abstract] [Full Text] [Related]

  • 17. Identification of Aurora-A Inhibitors by Ligand and Structure-Based Virtual Screening.
    Morshed MN.
    Mol Inform; 2014 May 01; 33(5):369-81. PubMed ID: 27485892
    [Abstract] [Full Text] [Related]

  • 18. A class of 2,4-bisanilinopyrimidine Aurora A inhibitors with unusually high selectivity against Aurora B.
    Aliagas-Martin I, Burdick D, Corson L, Dotson J, Drummond J, Fields C, Huang OW, Hunsaker T, Kleinheinz T, Krueger E, Liang J, Moffat J, Phillips G, Pulk R, Rawson TE, Ultsch M, Walker L, Wiesmann C, Zhang B, Zhu BY, Cochran AG.
    J Med Chem; 2009 May 28; 52(10):3300-7. PubMed ID: 19402633
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.